Browsing by Subject cell therapy
Showing results 1 to 7 of 7
Issue Date | Title | Author(s) |
---|---|---|
26-Feb-2018 | Cell therapy in organ transplantation: Our experience on the clinical translation of regulatory T cells | Safinia, N; Grageda, N; Scottà, C; Thirkell, S; Fry, LJ; Vaikunthanathan, T; Lechler, RI; Lombardi, G |
28-Jul-2021 | Chimeric antigen receptor-modified human regulatory T cells that constitutively express IL-10 maintain their phenotype and are potently suppressive | Mohseni, YR; Saleem, A; Tung, SL; Dudreuilh, C; Lang, C; Peng, Q; Volpe, A; Adigbli, G; Cross, A; Hester, J; Farzaneh, F; Scotta, C; Lechler, RI; Issa, F; Fruhwirth, GO; Lombardi, G |
20-Jul-2018 | Expanded regulatory T cells induce alternatively activated monocytes with a reduced capacity to expand T helper-17 cells | Romano, M; Fanelli, G; Tan, N; Nova-Lamperti, E; McGregor, R; Lechler, RI; Lombardi, G; Scottà, C |
11-Aug-2021 | In vivo cell tracking using pet: Opportunities and challenges for clinical translation in oncology | Lechermann, LM; Lau, D; Attili, B; Aloj, L; Gallagher, FA |
5-May-2021 | Isolation and expansion of thymus-derived regulatory T cells for use in pediatric heart transplant patients | Romano, M; Sen, M; Scottà, C; Alhabbab, RY; Rico-Armada, A; Lechler, RI; Burch, M; Lombardi, G |
2-Feb-2021 | Potential Application of T-Follicular Regulatory Cell Therapy in Transplantation | Dudreuilh, C; Basu, S; Scottà, C; Dorling, A; Lombardi, G |
31-Jan-2018 | A Rapamycin-Based GMP-Compatible Process for the Isolation and Expansion of Regulatory T Cells for Clinical Trials | Fraser, H; Safinia, N; Grageda, N; Thirkell, S; Lowe, K; Fry, LJ; Scottá, C; Hope, A; Fisher, C; Hilton, R; Game, D; Harden, P; Bushell, A; Wood, K; Lechler, RI; Lombardi, G |